StockNews.AI
ZBH
Benzinga
105 days

These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

1. ZBH reported Q1 adjusted EPS of $1.81, beating estimates of $1.77. 2. Sales reached $1.91 billion, slightly above the consensus of $1.9 billion. 3. Fiscal year 2025 EPS forecast lowered to $7.90-$8.10 from $8.15-$8.35. 4. Analysts adjusted price targets downward for ZBH post-earnings announcement. 5. Shares increased by 0.7% to $91.08 following earnings release.

4m saved
Insight
Article

FAQ

Why Neutral?

The earnings beat expectations, but lower EPS guidance and price target cuts may weigh on investor sentiment. Historical examples show that earnings beats often result in short-term stock price increases, yet negative guidance can counteract this effect.

How important is it?

The article directly addresses ZBH's earnings performance and analyst sentiment, crucial for stock price movement. Price target reductions from multiple analysts underline cautious outlook, affecting investor confidence.

Why Short Term?

Immediate effects noticeable in stock price due to earnings release, while lowered guidance dampens outlook, leading to potential volatility in the near term. Previous quarters with similar scenarios have shown mixed performance immediately post-earnings.

Related Companies

Related News